Literature DB >> 18571118

Isolation of Enterobacter sakazakii from ass' milk in Sicily: case report, safety and legal issues.

F Conte1, A Passantino.   

Abstract

Enterobacter sakazakii (Es) infections are likely to involve newborns and infants, causing meningitis and necrotizing enterocolitis and sepsis. Contamination of infant formulae milk during factory production or bottle preparation is implicated. Es has been isolated from environmental sources and from food other than infant formula and milk powder, but why it is associated only with the consumption of infant formulae, is unclear. According to Regulation (EC) No. 2073/2005 on the microbiological criteria for foodstuffs, Es is considered a microorganisms of greatest concern in infant formulae and follow-on formulae. Es is included between "safety criteria". The isolation of two strains of Es from 50 samples of ass' milk in Sicily is described. The antibiotic resistance profile of the isolates revealed a multiple resistance profile, including fluoroquinolones, commonly used to treat the infections. The authors underline the importance of survey because in Italy ass' milk is considered one of the solutions for infants suffering from hypersensitivity to milk protein of some animal species. There is scarce information about the ecology and the uncertainty concerning the source of infection in the children and adults; the authors are concerned that ass' milk could become a high-risk food.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571118     DOI: 10.1016/j.tmaid.2008.01.003

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  2 in total

1.  Isolation of Cronobacter spp. (Enterobacter Sakazakii) from Artisanal Mozzarella.

Authors:  Francesco Casalinuovo; Paola Rippa; Luciana Battaglia; Nicola Parisi
Journal:  Ital J Food Saf       Date:  2014-02-04

2.  Time for the 70°C water precautionary option in the home dilution of powdered infant formula.

Authors:  Marco Silano; Paola Paganin; Riccardo Davanzo
Journal:  Ital J Pediatr       Date:  2016-02-19       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.